Recent Achievements

  1. Adjuvantix has obtained compelling proof of principle for ADX40 in a number of model systems.
  2. Established clear proof of principle for the technology using a subunit
    influenza vaccine.
  3. Completed a BBSRC SBRI funded programme of work in collaboration with
    Lipoxen Ltd showing that showing that the liposomal route is an effective delivery mechanism.
  4. Made additional developments to the conjugation process that improves its reliability & consistency.